Older Adults With Diabetes and Low Body Weight May Be at Risk for Poorer Health Outcomes

For older adults living with type 2 diabetes (T2D), a lower body weight may actually be a harbinger of poor health outcomes rather than a sign of fitness. Contrary to long-held assumptions that lower weight always correlates with better health, a body mass index (BMI) below 22 kg/m² has been identified as an independent predictor of increased all-cause mortality in patients with diabetes aged 60 years and older. This finding, recently highlighted in a study of over 370,000 participants, suggests that maintaining a moderate body weight is significantly more conducive to better health for this demographic than being underweight.¹

The study published in Diabetology and Metabolic Syndrome indicates that low BMI in geriatric diabetes often reflects a state of metabolic wasting, sarcopenia, and depleted energy reserves rather than a healthy weight status. These altered body compositions can accelerate aging-related pathophysiological processes and leave older patients with reduced resilience to acute illnesses, such as infections or surgeries. For pharmacists, this represents a critical shift in risk assessment, as underweight patients with diabetes were found to have a 10% higher risk of mortality compared to those with a higher BMI.¹

A particularly complex challenge for clinical monitoring is the negative mediation effect of cholesterol levels in these patients, according to the study authors. They discovered that low BMI is associated with lower levels of total cholesterol and high-density lipoprotein cholesterol (HDL-C), which effectively masks the true magnitude of mortality risk. HDL-C exhibited the strongest masking effect, meaning that what might appear to be a favorable or normal cholesterol profile in an underweight patient could actually be a sign of metabolic wasting syndrome and impaired immune function. This suggests that pharmacists should view hypocholesterolemia in underweight older adults as a potential red flag for malnutrition or chronic inflammation rather than a successful lipid-lowering result.¹

This shift in geriatric care is echoed by broader research suggesting that the traditional benefits of weight control diminish as patients age. The association between obesity and the prevalence of T2D appears to weaken significantly in populations over the age of 75 years. Because of this, pharmacists and clinicians are advised to comprehensively balance the benefits and side effects of weight loss in older adults. Intensive weight loss interventions in the elderly can inadvertently worsen sarcopenia and osteoporosis, leading to an increased risk for falls and fractures.²

Furthermore, the clinical reliance on BMI as a sole metric of health can be deceptive in the geriatric population. Even patients who maintain a normal BMI may suffer from normal-weight obesity, a condition where a person has a normal weight but a high body fat percentage.³

These individuals are at an increased risk for cardiovascular disease and often display an exaggerated triglyceride response after meals, even when their fasting lipid levels appear unremarkable. Research suggests that trunk fat, rather than absolute weight, is more strongly correlated with these adverse metabolic responses.³

For pharmacists, these findings underscore the necessity of a nuanced approach to geriatric diabetes management that moves beyond simple glycemic and weight control. Practitioners should prioritize nutritional assessments and the preservation of lean muscle mass in their older patients, particularly those who are underweight or experiencing involuntary weight loss.¹

Monitoring for lipid metabolic disturbances in underweight patients and encouraging resistance training may be more vital for improving survival outcomes than pushing for traditional weight loss targets. By recognizing that low BMI may be a high-risk indicator, pharmacists can play a pivotal role in identifying vulnerable patients who require targeted nutritional support and more careful medication management.¹

READ MORE: Diabetes Resource Center

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips straight to your inbox.

REFERENCES

1. Mo H, Yang Q, Wang Y, et al. Low BMI predicts mortality in T2DM older adults: cholesterol parameters demonstrate negative mediation. Diabetol Metab Syndr. Published online March 3, 2026. doi:10.1186/s13098-026-02118-y

2. Zhou Q, Sun J, Wu Z, et al. The older, the less potential benefit for type 2 diabetes from weight control. BMC Geriatr. 2022;22(1):346. Published 2022 Apr 20. doi:10.1186/s12877-022-02979-8

3. Pathangi DO, Quirk AR, Schifferer JK, et al. Postprandial Cardiometabolic Parameters in Older Adults with Normal-Weight Obesity: A Cross-Sectional Pilot Study. Metabolites. 2025;15(8):550. Published 2025 Aug 15. doi:10.3390/metabo15080550